Coloplast A/S (OTCMKTS:CLPBY) Short Interest Update

Coloplast A/S (OTCMKTS:CLPBY) saw a significant decline in short interest in June. As of June 30th, there was short interest totalling 90,700 shares, a decline of 59.9% from the June 15th total of 226,200 shares. Based on an average trading volume of 238,400 shares, the short-interest ratio is presently 0.4 days.

Coloplast A/S Price Performance

Shares of Coloplast A/S stock remained flat at $12.74 during trading on Thursday. The stock had a trading volume of 39,388 shares, compared to its average volume of 175,782. The company has a market capitalization of $27.52 billion, a PE ratio of 38.61, a price-to-earnings-growth ratio of 3.12 and a beta of -0.03. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.39 and a current ratio of 0.60. Coloplast A/S has a 12-month low of $9.90 and a 12-month high of $14.34. The business has a 50 day simple moving average of $12.26 and a two-hundred day simple moving average of $12.51.

Coloplast A/S (OTCMKTS:CLPBY) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.08 EPS for the quarter, meeting analysts’ consensus estimates of $0.08. The business had revenue of $959.05 million for the quarter. Coloplast A/S had a net margin of 19.45% and a return on equity of 36.74%. On average, analysts forecast that Coloplast A/S will post 0.34 earnings per share for the current fiscal year.

Coloplast A/S Cuts Dividend

The firm also recently declared a dividend, which was paid on Tuesday, May 28th. Shareholders of record on Monday, May 20th were given a dividend of $0.0463 per share. The ex-dividend date of this dividend was Friday, May 17th. Coloplast A/S’s payout ratio is 27.27%.

Coloplast A/S Company Profile

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.